The name is the button.

An agent writes the code now, and a human thumb hovers over Accept all a hundred times a day. The honest question of this decade is what, exactly, you just accepted. So I read the diff.

Eight years as a backend engineer in Stockholm, back in Tokyo since 2023, and I still ship something small most nights, usually badly. My one rule: the only real review of a model is the thing you built with it. That is why there is no leaderboard on this site.

Around a hundred and forty sources come through — the labs' own posts, the papers, the tools, the runtimes and languages nobody is watching yet, the chip under the demo, and the newsletters people actually forward. What is moving gets counted so the week reads at a glance, and every few days I explain one mechanism in plain words.

A story here is a headline, a short excerpt, one image and the link to whoever wrote it. We never reproduce the post; the images belong to their authors. A post written in Japanese appears in Japanese, exactly as it was published, and the link goes to the original.

— Yuki Halvorsen, Tokyo

← Accept All Archive

NVIDIA NewsroomSilicon

European Mobility Leaders Build Safe Vehicles and Robotaxi Fleets on NVIDIA Hyperion

10.21

News Summary: Bolt with Lucid, Mercedes-Benz, Volkswagen Commercial Vehicles and Einride are showcasing selected autonomous-mobility use cases on the NVIDIA Hyperion computing platform, demonstrating…

Chips & compute Robotics & physical AI Press Releases Driving

Read at NVIDIA Newsroom ↗

One letter a week, starting soon.

Latest

European Mobility Leaders Build Safe Vehicles and Robotaxi Fleets on NVIDIA Hyperion

Related

SiliconScaling Data Movement For Physical AI SemiEngineering

ValleyEx-Nvidia-turned-VC Amulya Vishwanath: ‘Physical AI is in its LEGO era’ TechCrunch AI

VoicesPhysical AI at NVIDIA Software Engineering Daily

SiliconThe Machines that Make the Machines NVIDIA Technical Blog

VoicesOpen models and the future of Physical AI with NVIDIA Practical AI

SiliconHealthcare and Life Sciences Leaders Build on NVIDIA to Advance Drug Discovery and Expand Patient Care NVIDIA Newsroom